ArticleAlimentary pharmacology & therapeutics2025

Development and Validation of a PIVKA-II-Based Model for HCC Risk Stratification in Patients With HCV-Related Cirrhosis Successfully Treated With DAA.

Gian Paolo Caviglia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.